HomeORCHPHARMA • NSE
add
Orchid Pharma Ltd
Nakaraang pagsara
₹1,644.00
Sakop ng araw
₹1,577.90 - ₹1,664.05
Sakop ng taon
₹702.75 - ₹1,997.40
Market cap
81.15B INR
Average na Volume
67.26K
P/E ratio
66.79
Dividend yield
-
Primary exchange
NSE
Mga balita tungkol sa merkado
Mga Financial
Income Statement
Kita
Net na kita
| (INR) | Set 2024info | Y/Y na pagbabago |
|---|---|---|
Kita | 2.23B | 12.05% |
Gastos sa pagpapatakbo | 698.25M | 14.56% |
Net na kita | 272.36M | 37.53% |
Net profit margin | 12.23 | 22.79% |
Kita sa bawat share | 5.37 | — |
EBITDA | 302.47M | 30.11% |
Aktuwal na % ng binabayarang buwis | — | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (INR) | Set 2024info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 2.44B | 384.25% |
Kabuuang asset | 16.35B | 9.59% |
Kabuuang sagutin | 4.11B | 6.94% |
Kabuuang equity | 12.24B | — |
Natitirang share | 50.72M | — |
Presyo para makapag-book | 6.81 | — |
Return on assets | — | — |
Return on capital | 4.03% | — |
Cash Flow
Net change in cash
| (INR) | Set 2024info | Y/Y na pagbabago |
|---|---|---|
Net na kita | 272.36M | 37.53% |
Cash mula sa mga operasyon | — | — |
Cash mula sa pag-invest | — | — |
Cash mula sa financing | — | — |
Net change in cash | — | — |
Malayang cash flow | — | — |
Tungkol
Orchid Pharma Limited is an Indian pharmaceutical company based in Chennai, founded on 1 July 1992. As of 2024, it was among the top fortune 500 Indian companies by market capitalization. Orchid Pharma is the only pharma company in India to have discovered a New Drug Enmetazobactam which is now approved in United States, Europe and India. Wikipedia
Itinatag
1992
Website
Mga Empleyado
871
